Neurokinin receptor antagonists could play a role in the treatment of polycystic ovary syndrome (PCOS), a prevalent endocrine disorder characterized by hyperandrogenism and an elevated LH-to-FSH ratio [51]. The gene discussed is BRD2; the disease is polycystic ovary syndrome.